Literature DB >> 18182237

Kallikrein kinin system activation in post-exercise hypotension in water running of hypertensive volunteers.

Francisco L Pontes1, Reury F P Bacurau, Milton R Moraes, Francisco Navarro, Dulce E Casarini, Jorge L Pesquero, João B Pesquero, Ronaldo C Araújo, Ivan C Piçarro.   

Abstract

Previous studies demonstrated a reduction in blood pressure level immediately after different types of exercises, like running, cycling and resistance training, a phenomenon called post-exercise hypotension (PEH). Since PEH can persist for hours it could be suggested as a non-pharmacological therapy for hypertensive individuals. Unfortunately, usually running is not recommended due to the high impact caused by its practice. Therefore running in water treadmill should be a better option, since the environment is completely different and causes lower impact. However it is not known whether PEH occurs in this situation. The objective of this work was to evaluate the existence of PEH after water running and to compare PEH promoted by running in two different environments. In addition, changes in plasmatic concentrations of the kallikrein kinin system (KKS) components were also evaluated. Sixteen hypertensive subjects were submitted to two exercise sessions, conventional running and water running, in two different occasions. The pattern of heart rate, blood pressure and plasmatic concentrations of KKS components immediately after and one hour after exercise were investigated. Results showed a maximal reduction in systolic and diastolic blood pressure 30 min after both exercise models (P<0.001), indicating that moderate water running promotes PEH with similar magnitude as compared to conventional running. Plasma kallikrein activity and bradykinin concentration increased immediately after exercise (P<0.05), but these parameters were not different in both exercise models. In conclusion, our findings show that water running, similarly to conventional running, can also provoke PEH and alterations in the KKS components.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18182237     DOI: 10.1016/j.intimp.2007.09.001

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  11 in total

1.  Subacute blood pressure response in elderly hypertensive women after a water exercise session : a controlled clinical trial.

Authors:  Raphael M Cunha; Camilla B Macedo; Siomara F M Araújo; Jessica C Santos; Viviane S Borges; Ademar A Soares; Flávio Ayres; Linda M Pfrimer
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-02-19

2.  Leptin regulates ACE activity in mice.

Authors:  Aline Mourao Hilzendeger; Rafael Leite Morais; Mihail Todiras; Ralph Plehm; Andrey da Costa Goncalves; Fatimunnisa Qadri; Ronaldo Carvalho Araujo; Volkmar Gross; Clovis Ryuichi Nakaie; Dulce Elena Casarini; Adriana Karaoglanovic Carmona; Michael Bader; João Bosco Pesquero
Journal:  J Mol Med (Berl)       Date:  2010-07-08       Impact factor: 4.599

3.  Post-exercise hypotension and heart rate variability response after water- and land-ergometry exercise in hypertensive patients.

Authors:  Danilo Sales Bocalini; Marco Bergamin; Alexandre Lopes Evangelista; Roberta Luksevicius Rica; Francisco Luciano Pontes; Aylton Figueira; Andrey Jorge Serra; Emilly Martinelli Rossi; Paulo José Ferreira Tucci; Leonardo Dos Santos
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

4.  Exercise on land or in water?

Authors:  Alain Boussuges; Olivier Gavarry
Journal:  Int J Gen Med       Date:  2012-04-02

5.  Hypotensive response after water-walking and land-walking exercise sessions in healthy trained and untrained women.

Authors:  Daniel Rodriguez; Valter Silva; Jonato Prestes; Roberta Luksevicius Rica; Andrey Jorge Serra; Danilo Sales Bocalini; Francisco Luciano Pontes
Journal:  Int J Gen Med       Date:  2011-08-10

6.  Exercise lowers blood pressure in university professors during subsequent teaching and sleeping hours.

Authors:  Fabiana Ribeiro; Carmen S Grubert Campbell; Gisele Mendes; Gisela Arsa; Sérgio R Moreira; Francisco M da Silva; Jonato Prestes; Rafael da Costa Sotero; Herbert Gustavo Simões
Journal:  Int J Gen Med       Date:  2011-10-19

7.  Exercise training can prevent cardiac hypertrophy induced by sympathetic hyperactivity with modulation of kallikrein-kinin pathway and angiogenesis.

Authors:  José Antônio Silva; Eduardo Tadeu Santana; Martha Trindade Manchini; Ednei Luis Antônio; Danilo Sales Bocalini; José Eduardo Krieger; Paulo José Ferreira Tucci; Andrey Jorge Serra
Journal:  PLoS One       Date:  2014-03-10       Impact factor: 3.240

8.  Association of cardiovascular response to an acute resistance training session with the ACE gene polymorphism in sedentary women: a randomized trial.

Authors:  Jéssica Cardoso de Souza; Ramires Alsamir Tibana; Nuno Manuel Frade de Sousa; Vinícius Carolino de Souza; Margô G O Karnikowski; Jonato Prestes; Carmen Silvia Grubert Campbell
Journal:  BMC Cardiovasc Disord       Date:  2013-01-10       Impact factor: 2.298

9.  Type 2 diabetes elicits lower nitric oxide, bradykinin concentration and kallikrein activity together with higher DesArg(9)-BK and reduced post-exercise hypotension compared to non-diabetic condition.

Authors:  Herbert Gustavo Simões; Ricardo Yukio Asano; Marcelo Magalhães Sales; Rodrigo Alberto Vieira Browne; Gisela Arsa; Daisy Motta-Santos; Guilherme Morais Puga; Laila Cândida de Jesus Lima; Carmen Sílvia Grubert Campbell; Octavio Luiz Franco
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

10.  Amelioration of cardiac function and activation of anti-inflammatory vasoactive peptides expression in the rat myocardium by low level laser therapy.

Authors:  Martha Trindade Manchini; Andrey Jorge Serra; Regiane dos Santos Feliciano; Eduardo Tadeu Santana; Ednei Luis Antônio; Paulo de Tarso Camillo de Carvalho; Jairo Montemor; Renato Oliveira Crajoinas; Adriana Castello Costa Girardi; Paulo José Ferreira Tucci; José Antônio Silva
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.